Singapore markets closed
  • Straits Times Index

    +8.98 (+0.36%)
  • Nikkei

    +42.32 (+0.18%)
  • Hang Seng

    +132.65 (+0.54%)
  • FTSE 100

    +74.63 (+1.29%)

    +55.20 (+0.43%)
  • CMC Crypto 200

    -1.40 (-0.54%)
  • S&P 500

    +11.90 (+0.34%)
  • Dow

    -28.09 (-0.10%)
  • Nasdaq

    +42.28 (+0.37%)
  • Gold

    -1.20 (-0.06%)
  • Crude Oil

    -0.86 (-2.12%)
  • 10-Yr Bond

    -0.0070 (-0.83%)
  • FTSE Bursa Malaysia

    -4.16 (-0.28%)
  • Jakarta Composite Index

    +20.37 (+0.40%)
  • PSE Index

    +139.43 (+2.20%)

Europe Migraine Market and Competitive Landscape Report 2020 -

·3-min read

The "Europe Migraine Market and Competitive Landscape - 2020" report has been added to's offering.

Europe Migraine Market and Competitive Landscape - 2020, provides comprehensive insights into the Migraine pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Migraine market size and drug sales. It also provides insights into Migraine epidemiology and late stage pipeline.

This research covers the following:

Migraine treatment options, Migraine late stage clinical trials pipeline, Migraine prevalence by countries, Migraine market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

  • Countries: Germany, France, Italy, Spain, UK, Europe

  • Migraine pipeline: Find out drugs in clinical trials for the treatment of Migraine by development phase 3, phase 2, and phase 1, by pharmacological class and company

  • Migraine epidemiology: Find out the number of patients diagnosed (prevalence) with Migraine by countries

  • Migraine drugs: Identify key drugs marketed and prescribed for Migraine in the US, including trade name, molecule name, and company

  • Migraine drugs sales: Find out the sales value for Migraine drugs by countries

  • Migraine market valuations: Find out the market size for Migraine drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024

  • Migraine drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research:

  • Evaluate commercial market opportunities for Migraine drugs

  • Synthesize insights for business development & licensing

  • Track market size, competitor drug sales, market shares in the Migraine market

  • Develop in-depth knowledge of competition and markets

  • Analyze Migraine drug sales data to update your brand planning trackers

  • Develop tactics and strategies to take advantage of opportunities in the market

  • Track Market Events and Trends and analyze key events in the Migraine market

  • Develop forecast models, healthcare frameworks, or economic models

  • Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Migraine Treatment Options

2. Migraine Pipeline Insights

2.1. Migraine Phase 3 Clinical Trials

2.2. Migraine Phase 2 Clinical Trials

2.3. Migraine Phase 1 Clinical Trials

3. Migraine Epidemiology Analysis by Countries

4. Germany Migraine Market Insights

4.1. Marketed Drugs for Migraine in Germany

4.2. Germany Migraine Market Size & Forecast

4.3. Germany Migraine Drugs Sales Forecast

4.4. Germany Migraine Market Share Analysis

5. France Migraine Market Insights

5.1. Marketed Drugs for Migraine in France

5.2. France Migraine Market Size & Forecast

5.3. France Migraine Product Sales Forecast

5.4. France Migraine Market Share Analysis

6. Italy Migraine Market Insights

6.1. Marketed Drugs for Migraine in Italy

6.2. Italy Migraine Market Size & Forecast

6.3. Italy Migraine Product Sales Forecast

6.4. Italy Migraine Market Share Analysis

7. Spain Migraine Market Insights

7.1. Marketed Drugs for Migraine in Spain

7.2. Spain Migraine Market Size & Forecast

7.3. Spain Migraine Product Sales Forecast

7.4. Spain Migraine Market Share Analysis

8. UK Migraine Market Insights

8.1. Marketed Drugs for Migraine in UK

8.2. UK Migraine Market Size & Forecast

8.3. UK Migraine Product Sales Forecast

8.4. UK Migraine Market Share Analysis

9. Europe Migraine Market Insights

9.1. Europe Migraine Market Size & Forecast

9.2. Europe Migraine Product Sales Forecast

9.3. Europe Migraine Market Share Analysis

10. Research Methodology

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900